Time to Call into Question the Fundus-based Evaluation of Diabetic Retinopathy after Intravitreal Injections.
作者信息
Tadayoni Ramin
机构信息
Université de Paris, Ophthalmology Department, AP-HP, Hôpital Lariboisière, F-75010, Paris, France.
出版信息
J Ophthalmic Vis Res. 2020 Feb 2;15(1):4-6. doi: 10.18502/jovr.v15i1.5971. eCollection 2020 Jan-Mar.
Abstract
摘要
相似文献
1
Time to Call into Question the Fundus-based Evaluation of Diabetic Retinopathy after Intravitreal Injections.是时候对玻璃体内注射后糖尿病视网膜病变的基于眼底的评估提出质疑了。
J Ophthalmic Vis Res. 2020 Feb 2;15(1):4-6. doi: 10.18502/jovr.v15i1.5971. eCollection 2020 Jan-Mar.
2
Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.非肥胖型糖尿病小鼠眼内致炎细胞因子：模拟糖尿病性视网膜病变的特征。
PLoS One. 2018 Aug 22;13(8):e0202156. doi: 10.1371/journal.pone.0202156. eCollection 2018.
3
Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1.在一项前瞻性随机试验中，通过眼底荧光血管造影在 4 个月时观察黄斑灌注，比较玻璃体内注射贝伐单抗或激光治疗糖尿病性黄斑水肿（Bolt 研究）：报告 1。
Retina. 2010 May;30(5):781-6. doi: 10.1097/iae.0b013e3181d2f145.
4
Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study.玻璃体内注射甲氨蝶呤治疗持续性糖尿病黄斑水肿：一项6个月的随访研究。
Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2159-2164. doi: 10.1007/s00417-016-3374-2. Epub 2016 May 5.
5
Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.玻璃体内注射曲安奈德作为增殖性糖尿病视网膜病变玻璃体切割术的辅助手段。
Eur J Ophthalmol. 2003 Jun;13(5):468-73. doi: 10.1177/112067210301300508.
6
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.玻璃体内注射 0.19mg 氟轻松醋酸酯植入物对糖尿病视网膜病变进展和消退的长期影响。
Ophthalmology. 2017 Apr;124(4):440-449. doi: 10.1016/j.ophtha.2016.11.034. Epub 2017 Jan 9.
7
Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.短期玻璃体内注射曲安奈德、地塞米松植入物或贝伐单抗后糖尿病性黄斑水肿中硬性渗出物的定量评估。
BMC Ophthalmol. 2017 Oct 3;17(1):182. doi: 10.1186/s12886-017-0578-0.
8
Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).全视网膜光凝术与全视网膜光凝术联合玻璃体内注射贝伐单抗治疗高危增殖性糖尿病视网膜病变（IBeHi研究）
Acta Ophthalmol. 2008 Jun;86(4):385-9. doi: 10.1111/j.1600-0420.2007.01056.x. Epub 2007 Nov 7.
9
Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema.玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿后的屈光变化。
Clin Exp Optom. 2018 May;101(3):397-399. doi: 10.1111/cxo.12637. Epub 2017 Nov 14.
10
Changes of serum VEGF concentration after intravitreal injection of Avastin in treatment of diabetic retinopathy.玻璃体腔内注射阿瓦斯汀治疗糖尿病性视网膜病变后血清血管内皮生长因子浓度的变化
Eur J Ophthalmol. 2012 Sep-Oct;22(5):792-8. doi: 10.5301/ejo.5000118.
引用本文的文献
1
Effectiveness of artificial intelligence for diabetic retinopathy screening in community in Binh Dinh Province, Vietnam.人工智能在越南平定省社区糖尿病视网膜病变筛查中的有效性
Taiwan J Ophthalmol. 2024 Sep 13;14(3):394-402. doi: 10.4103/tjo.TJO-D-23-00101. eCollection 2024 Jul-Sep.
2
Perspectives of diabetic retinopathy-challenges and opportunities.糖尿病视网膜病变的研究进展：挑战与机遇
Eye (Lond). 2023 Aug;37(11):2183-2191. doi: 10.1038/s41433-022-02335-5. Epub 2022 Dec 9.
本文引用的文献
1
Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.宽视野 OCT 血管造影和荧光素血管造影评估抗血管内皮生长因子治疗糖尿病视网膜病变和水肿的无灌注区。
Ophthalmology. 2019 Dec;126(12):1685-1694. doi: 10.1016/j.ophtha.2019.06.022. Epub 2019 Jun 26.
2
Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.抗血管内皮生长因子治疗糖尿病视网膜病变：意外治疗中断的后果。
Am J Ophthalmol. 2019 Aug;204:13-18. doi: 10.1016/j.ajo.2019.03.005. Epub 2019 Mar 13.
3
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION.抗血管内皮生长因子治疗可改善糖尿病视网膜病变评分而不改变视网膜灌注。
Retina. 2019 Mar;39(3):426-434. doi: 10.1097/IAE.0000000000002422.
4
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变的随机临床试验
JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217.
5
Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.雷珠单抗治疗对糖尿病视网膜病变严重程度和视网膜病变恶化的基线危险因素的长期影响。
Ophthalmology. 2015 Feb;122(2):367-74. doi: 10.1016/j.ophtha.2014.08.048. Epub 2014 Nov 18.
6
Zotero 插件